Comprehensive Stability Study Protocol for Drug Implants
This protocol outlines the procedures for conducting stability studies on drug implants, assessing drug release, mechanical integrity, and sterility under various storage conditions.
| Parameter | Details |
|---|---|
| Product Name | [Drug Implant Name] |
| Batch Number | [Batch Number] |
| Objective | To evaluate the stability of drug implants under specified environmental conditions. |
| Test Parameters |
– Drug Release Profile – Mechanical Integrity  |
| Storage Conditions | [e.g., 25°C/60% RH, 40°C/75% RH] |
| Test Intervals | [Specify intervals: 0, 3, 6 months, etc.] |
| Acceptance Criteria | No significant changes in drug release profile, sterility, or mechanical integrity. |
| Regulatory Guidelines | ICH Q1A(R2), FDA, EMA |
| Signatories | QA, QC, Regulatory Affairs |